SquareMind Secures $18 Million Funding Led By Sonder Capital And Fred Moll For AI Dermatology Solutions

SquareMind, a robotics company based in Paris, raised $18 million in funding led by Sonder Capital and Fred Moll, the founder of Intuitive Surgical. This investment included participation from Deeptech 2030 Fund, Adamed Technology, Calm/Storm Ventures, Teampact Ventures, and various entrepreneurs.

Summary of transaction details:

• Deal Type: Funding
• Transaction Amount: $18,000,000
• Company: SquareMind
• Key Executives: Ali Khachlouf (CEO) and Tanguy Serrat
• Headquarters: Paris, Île-de-France, France
• Notable Investors: Sonder Capital, Fred Moll, Deeptech 2030 Fund, Adamed Technology, Calm/Storm Ventures, Teampact Ventures

SquareMind specializes in AI-driven dermatology solutions, with its flagship product, Swan, being FDA-listed and CE-marked. This product employs a robotic system to facilitate fast, contactless skin exams, where patients are supported by audiovisual prompts. The company aims to utilize the newly acquired capital to enhance its commercial, engineering, and customer support teams in anticipation of a near-term launch of its platform.